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The number of articles on alexithymia has been steadily increasing since the word “alexithymia” was coined in
the 1970s to denote a common characteristic that is observed among classic psychosomatic patients in whom
therapy was unsuccessful. Alexithymia, a disorder of affect regulation, has been suggested to be broadly
associated with various mental and physical health problems. However, most available evidence is based on
anecdotal reports or cross-sectional observations. To clarify the predictive value of alexithymia for health
problems, a systematic review of prospective studies was conducted. A search of the PubMed database
identified 1,507 articles on “alexithymia” that were published by July 31, 2011. Among them, only 7 studies
examined the developmental risks of alexithymia for health problems among nonclinical populations and 38
studies examined the prognostic value of alexithymia among clinical populations. Approximately half of the
studies reported statistically significant adverse effects, while 5 studies demonstrated favorable effects of
alexithymia on health outcomes; four of them were associated with surgical interventions and two involved
cancer patients. The studies that showed insignificant results tended to have a small sample size. In conclusion,
epidemiological evidence regarding alexithymia as a prognostic risk factor for health problems remains
un-established. Even though alexithymia is considered to be an unfavorable characteristic for disease control
and health promotion overall, some beneficial aspects are suggested. More prospective studies with sufficient
sample sizes and follow-up period, especially those involving life course analyses, are needed to confirm the
contribution of alexithymia to health problems.
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Alexithymia, a personality construct that reflects difficul-
ties in affective self-regulation [1], was originally noted
by psychotherapists as a common characteristic
observed among classic psychosomatic patients in whom
therapy was unsuccessful [2]. To date, researchers have
revealed that alexithymia is broadly associated with vari-
ous mental and physical health problems. It is now
regarded as a key factor affecting treatment responses
across the field of medical practice [3].
How is alexithymia associated with the development
of health problems and their prognoses? Some of theCorrespondence: masayok@med.nagoya-cu.ac.jp
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reproduction in any medium, provided the orpossible underlying mechanisms have been well docu-
mented in previous review articles [1,4,5]. First, alexithy-
mic individuals have impaired emotion-processing and
regulating capacities which might induce disruption of
homeostasis through alterations of autonomic, endo-
crine, and immune activities [1]. Second, alexithymic
patients have a limited ability to cope adaptively with
stressful situations and tend to have unhealthy beha-
viors, such as poor nutrition, alcohol and drug use, and
a sedentary lifestyle [4,5]. Third, alexithymic patients
have difficulties in recognizing their own physical and
emotional symptoms, which may be linked to a delay or
excessive use of medical support, resulting in a poor
prognosis. Finally, because of their difficulties communi-
cating their own inner feelings and a poor understanding
of other people’s emotions, alexithymic patients find ithis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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others and to appropriately utilize social supports in
order to protect themselves from the potentially patho-
logical influences of stressful events [6].
Thus, theoretically, there is no doubt that alexithymia
plays a key role in disease control and health promotion.
Review of prospective cohort studies on alexithymia
Prospective cohort studies are the best type of observa-
tional design applied to examine the etiology and prog-
nosis of health problems [7]. Since Sifneos introduced
the concept of alexithymia in 1973 [2], the number of
articles regarding alexithymia has been increasing year
by year. According to the review by Taylor and Bagby
published in 2004 [8], a search of the PsycINFO data-
base revealed more than 1,000 journal articles on alex-
ithymia, while approximately 120 publications on
alexithymia had appeared by the mid-80s. However,
most of them were anecdotal or cross-sectional data
reports. To update the evidence and clarify the predict-
ive value of alexithymia as a health determinant, a brief
systematic review of the epidemiological literature was
conducted.
Method of systematic review
The minimum criteria for studies to be included in the
current review were as follows: (1) a prospective design
with a clinical or nonclinical population sample, (2)
evaluating the effects of baseline alexithymia on health-
related outcomes, (3) using validated methods to assess
alexithymia, and (4) written in English. To capture the
broad linkage between alexithymia and health outcomes,
the types of treatments and outcomes were not specified
in the process of data collection. P ≤ 0.05 was consid-
ered statistically significant.
A systematic search was conducted using the PubMed
database limiting the period from January 1, 1975 to July
31, 2011. A total of 1,507 documents were identified
using [“alexithymia” or “alexithymic”] as search terms.
By further adding [“prospective” or “prognostic” or “co-
hort” or “follow”] to the search terms, the search yielded
193 titles. After excluding 19 articles that were written
in non-English languages and 8 articles that were pub-
lished as a review, the remaining 166 articles were
inspected manually. Among them, only 7 articles were
identified as those reporting the developmental risks of
alexithymia for health problems among nonclinical
populations, and 38 articles were identified as those
reporting the influences of alexithymia on prognosis or
results of interventions among hospital-based popula-
tions. The reason for exclusion of most studies was the
cross-sectional design of data collection (n = 106). Fif-
teen studies were excluded even though they were pro-
spectively designed because they treated alexithymia asan outcome. Three articles were excluded because they
were editorials or commentaries.
Almost all studies included in the current review used
the Toronto Alexithymia Scale (TAS) or TAS-20 [9,10]
as a tool for evaluating alexithymia. Only two studies
used other tools; one study used the Beth Israel Ques-
tionnaire and Schalling-Sifneos Personality Scale [11],
and the other study used projective personality tests
[12,13]; they were included in the current review.
Major findings from nonclinical population studies
Table 1 shows the summary of studies examining the
effects of alexithymia on health outcomes with a pro-
spective design in a nonclinical population. Seven stud-
ies prospectively examined the developmental risks of
alexithymia for health problems among nonclinical
populations [14-20]. Among them, 3 studies demon-
strated the statistically significant adverse risk of baseline
alexithymia for subsequent health problems [14-16], 3
studies reported no association [18-20], and one
reported the beneficial effect of alexithymia on health
[17].
Two studies were based on the same large cohort data
derived from the Finnish general male population and
demonstrated the statistically significant adverse effects
of alexithymia on total mortality and/or cardiac death
[14,15]. A recently conducted cross-sectional study has
reported results which may support the findings of these
studies. Grabe et al examined 1,168 subjects who were
randomly selected from the general population and
found a significant association of alexithymia with
hypertension and atherosclerotic plaques [21]. The
authors pointed out that alexithymia may serve as a
long-standing risk factor as well as a familial and genetic
factor that deregulates the autonomic nervous system
[21]. Autonomic nervous deregulation may positively in-
fluence the developmental risk for cardiac death and
total mortality.
The most recently published Finnish report failed to
show a significant association between baseline alexithy-
mia and subsequent psychiatric diagnoses, such as major
depression, personality disorder, and alcohol use disor-
ders, which were confirmed by a structured clinical
interview [18]. However, the report is based on the sub-
sample data (n = 290) selected from a general population
cohort (n = 2,050) by the presence or absence of chronic
high mental symptoms. The study subjects were limited
to those who completed the successive 3-year follow-up
surveys (1998, 1999, and 2001) and a 7-year follow-up
survey including a structured interview (2005). It cannot
be denied that a considerable number of alexithymic
participants might have developed mental disorders be-
fore 2005 and quit the study, which may have caused
underestimation of the impact of alexithymia. In










Adverse 2321 General population 20 years Cardiac death Finland 2010 14
Adverse 2297 General population 5.5 years All cause morality Finland 1996 15
Adverse 54 Police officer 2 years PTSD USA 2006 16
Beneficial 1207 Urban public transit Operators 7.5 years Low back pain USA 2007 17
No association 333 Subsample selected from general population
cohort study sample
7 years Depression Finland 2010 18
No association 154 General population 30-22 years Neck-shoulder and
low-back pain
Finland 1991 19
No association 43 Fire fighter 2 years PTSD Switzerland 2005 20
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toms (BDI sum score) in logistic regression analysis to
estimate the developmental risk of depression and that
might have caused over adjustment [22]. In fact, the
results of simple Chi square tests suggested significantly
higher prevalence of such psychiatric diagnoses among
those who had a TAS-20 sum score above the median
[18].
Two studies examined the predictive value of alexithy-
mia on the development of low-back pain (LBP) [17,19].
One study found no association between baseline alex-
ithymia that was evaluated by projective personality tests
and the reported severity of neck–shoulder pain and/or
LBP among 154 subjects, randomly selected from the
general population [19]. The other study examined 1,207
municipal bus drivers and found a favorable association
between alexithymia and the 7.5-year incidence of com-
pensated LBP [17]. Inversely, the same research group
reported an adverse association between alexithymia and
LBP claims from cross-sectional data derived from the
same population [23]. The authors speculated that the
prevalence of self-reported LBP symptoms and the inci-
dence of compensated LBP claims are not comparable
even within the same population, and it might be diffi-
cult for alexithymic patients to complete the bureau-
cratic process to receive compensation, resulting in the
low prevalence of compensated LBP [17].
Two studies examined the developmental risks of
alexithymia for post-traumatic stress disorder (PTSD)
and the results were inconsistent [16,20]. One study
examined 43 male firefighters for 2 years and found no
significant risk of alexithymia [20]. The other study
examined 54 police officers and reported that their TAS-
20 scores significantly predicted PTSD symptoms for 2
years [16]. Both studies have too small sample size to
estimate the developmental risk of PTSD associated with
alexithymia. Further studies with sufficient sample
size and follow-up period are necessary to confirm the
vulnerability of alexithymic individuals to PTSD.Major findings from clinical population studies
A summary of studies examining the effect of alexithy-
mia on health outcomes with a prospective design in a
clinical population is shown in Table 2. In total, 38 arti-
cles were identified that reported the clinical impacts of
alexithymia on prognosis [24-61]. Major types of partici-
pants were patients with psychiatric or psychosomatic
illness recruited consecutively and the main outcome
was the treatment response. Most of them were prelim-
inary, naturalistic studies without control groups. Some
studies assigned subjects to a specific treatment or other
intervention, but none reported the blinding procedure.
Overall, information to evaluate the risk of bias of each
study is very limited; therefore, the presence of serious
risk of bias should be considered to interpret the results.
The number of studies reporting the adverse effects of
alexithymia was 18 [24-41], which was approximately
50% of the total studies. Five studies demonstrated
the beneficial effects of alexithymia on clinical out-
comes [42-46]. One-third of the identified clinical
studies (n = 15) reported no statistically significant asso-
ciations between baseline alexithymia and treatment out-
comes [47-61]. The studies that failed to find significant
associations between alexithymia and clinical outcomes
tended to have small sample sizes (median = 54, min = 19,
max = 297) [47-61] compared with those that dem-
onstrated significant results (median = 103, min = 30,
max = 480) [24-46].
The influence of alexithymia on the treatment process
and outcomes has been discussed intensively by Lumley
et al [4,5]. They speculated that alexithymic patients
might respond poorly to psychological treatments, al-
though perhaps not to cognitive behavioral techniques
because the compulsive nature and external focus of
people with alexithymia may prompt greater adherence
to structured exercises and behavioral recommendations
[4]. The current review does not identify clear differ-
ences by the types of therapy in the influences of alex-
ithymia on the outcomes. However, relatively consistent
Table 2 Studies examining the effects of alexithymia on health outcomes with a prospective cohort design in
clinicalpopulation
Type of participants Follow up
period
Type of treatment Type of main outcome N Country Ref.
no.
Adverse effect
Psychiatric inPT 4, 8-12W Multimodal psychotherapy Global severity Index and
depression severity
480 Germany 24
Substance users 10+15W Motivational intervention Response to treatment 260 USA 25
Psychiatric outPT 12-21 W Short-term psychotherapy Psychiatric symptomatology 251 Canada 26
Hemodialysis outPT 5Y Hemodialysis therapy All cause mortality 230 Japan 27
Hemodialysis outPT 6M Hemodialysis therapy Depression deterioration 230 Japan 28
OutPT with possible 6Y Pyschotherapy Recovery from depression 121 Finland 29
Veterans with military sexual
trauma.
7W Specialized residential treatment Symptom persistence 175 USA 30
Women taking elective surgical
abortion
2M Surgical abortion Re-experience and avoidance 140 Netherlands 31
OutPT with functional
gastrointestinal disorders
6M Unspecified treatment Response to treatment 112 Italy 32
PT taking implantable cardioverter
defibrillator
2-5.5 Y ICD placement Posttraumatic stress 107 Switzerland 33
Eating disorder PT 3Y Drug treatment and
psychotherapy
PT’ compliance and types of
treatments
102 France 34
Eating disorder PT 3Y Unspecified treatment Response to treatment 102 France 35
OutPT with major depression 1Y Unspecified treatment Response to treatment 86 Finland 36
PT with asthma 2Y Unspecified treatment Emargency room visits and QOL
(SF-36)
76 Spain 37
OutPT with major depression 10W Antidepressant Reduction of depression severity 65 Turkey 38
PT with type 1 Diabetes 8W Inpatient treatment Decrease in HbA1c 64 Belgium 39
Alcohol abuser 15W Inpatient treatment Maintaining abstinent 46 France 40
PT with somatoform and anxiety
disorder
2Y Inpatient treatment Symptom persistence 30 Austria 41
Beneficial effect
Cancer PT 6M Multicomponent psychological
intervention
Pain 104 Italy 42
PT taking in vitro fertilization 6M In vitro fertilization Delivery of a living infant 81 Greece 43
Colorectal cancer PT 3Y Surgery QOL (SF-36) 60 Italy 44
Ulcerative colotis PT 17M Pelvic pouch surgery Psychosocial adjustment 53 Sweden 45
Gynecologic PT 1M Laparoscopy or laparotomy QOL (SF-36) 40 Italy 46
No association
Psychiatric inPT 4, 8-12W Psychodynamic group therapy Global severity Index and
depression severity
297 Germany 47
OutPT with unexplained physical
symptom
6W Unspecified treatment Symptom persistence 127 Netherland 48
Pregnant women 1M Unspecified Depression development 149 Italy 49
PT with psoriasis 6M Cognitive behavioral therapy Response to treatment 80 UK 50
Obese outPT 8M Behavioral program Compliance and weight loss 68 Italy 51
InPT taking respiratory
rehabilitation
4W Respiratory rehabilitation Functional recovery 60 Italy 52
Panic disorder PT 6M CBT Response to treatment 55 Switzerland 53
Psychiatric consultation outPT 1Y Psychotherapy PT’s compliance 54 Finland 54
OCD inPT 31-139 D Multimodal CBT Response to treatment 42 Germany 55
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Table 2 Studies examining the effects of alexithymia on health outcomes with a prospective cohort design in
clinicalpopulation (Continued)
Bulmia nervosa PT 10W Drug treatment Symptom improvements 41 England 56
CFS outPT 18M Unspecified treatment Symptom improvements 40 Netherland 57
OutPT with psoriasis 3M Delmatological treatment Response to treatment 40 France 58
OCD inPT 6Y Inpatient treatment OCD deteriotion 34 Switzerland 59
Schizophrenia outPT 1Y Appropriate treatment Symptom improvements 29 Italy 60
Eating disorder inPT 1Y Psychoeducation Dietary restraint 19 Switzerland 61
PT=patient, OCD=obsessive-compulsive disorders, CFS=chronic fatigue syndrome, CBT=cognitive behavioral therapy, W=week, M=month, Y=year.
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with surgical interventions [43-47].
To date, the association between surgical treat-
ments and alexithymia has rarely been discussed.
Kakatsaki et al examined 81 women undergoing an
in vitro fertilization program during a 6 month
period and found that alexithymia predicted better
outcome; delivery of a living infant [43]. Ripetti et al
examined a series of 60 colorectal cancer patients
with a three-month follow-up and found that a high-
level alexithymia group (TAS-20 ≥51) showed more
improvement in QOL measured by SF-36 test after
surgery than did the low-level alexithymia group
[44]. Weinryb et al examined 53 consecutive patients
undergoing pelvic pouch surgery and followed them
for 16 to 41 months [45]. They found that the level
of alexithymia measured by the Beth Israel Question-
naire was inversely correlated with worse psycho-
logical distress and adjustment in relationships at
home after surgery. Battista et al examined 40 con-
secutive patients with benign gynecologic pathology
who underwent laparoscopy or laparotomy and found
that patients with low-level of alexithymia (TAS-20≤
59) showed a worsening of QOL score measured by
SF-36 after a surgical procedure [46]. In general, sur-
gical treatment procedures are highly structured and
active so that the externally oriented thinking style
of alexithymic patients may suit them well. Ripetti
et al speculated that patients with alexithymia might
perceive invasive surgery to be effective because
surgical treatment leaves a visible body sign [44].
Weinryb et al suggested that patients with alexithy-
mia may tend to have avoidant coping strategies to
the negative aspects of surgery such that they may
have better recovery during the postoperative period
[45]. On the contrary, a study investigating short
term re-experiencing and avoidance after surgical
abortion conducted by van Emmerik et al demon-
strated a significant adverse effect of alexithymia on
the outcomes [31]. Because of the variety of the
study backgrounds and the types of treatments and
outcomes, we cannot draw definite conclusions from
the available data. Further research will be necessaryto fully disclose the favorable aspects of alexithymia
on treatment outcomes.
One prospective study involving cancer patients con-
ducted by Tulipani showed a significant beneficial effect
of alexithymia on reduction in pain perception by psy-
chological intervention to cancer patients [42]. They
recruited study participants consecutively, and randomly
allocated them to an intervention group or a control
group. A total of 52 cancer patients were provided the
6-month psychological intervention with a variety of
therapeutic approaches according to guidelines issued in
the literature on alexithymia and cancer pain and com-
pared to 52 controls. Psychological intervention signifi-
cantly reduced alexithymia as well as pain. Multiple
regression analysis showed that baseline alexithymia and
psychological intervention were both independently
associated with a reduction in pain perception. The role
of alexithymia in cancer patients is still under study [62].
The effectiveness of intervention focusing on the reduc-
tion of alexithymia to improve QOL should be examined
among cancer patients and other populations in future
research.
Most studies examined the associations between base-
line alexithymia and treatment outcomes, whereas only
one study reported the 5-year total mortality risk of alex-
ithymia [27]. Interestingly, the increased risk of total
mortality associated with alexithymia in hemodialysis
patients (multivariate adjusted hazard ratio = 3.62; 95%
CI: 1.32–9.93) was higher than that observed among
Finnish middle-aged men (1.96; 1.31–2.94) [15].
Whether or not the impact of alexithymia on total mor-
tality may differ by populations should be further
investigated.
Issues for future epidemiological research on alexithymia
Although alexithymia has been considered an unfavor-
able personality dimension for health promotion and
disease prevention, the results of epidemiological studies
were inconsistent. Most of them are preliminary and
have many methodological problems. Apparently, we
need more systematic, prospective studies with sound
design to verify each pathway explaining the relationship
between alexithymia and health problems that have been
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points to be followed when conducting an epidemio-
logical study to clarify the influence of alexithymia on
health. First, alexithymia is considered a relatively stable
characteristic, but it is actually dependent on psycho-
logical and/or physical conditions. Therefore, alexithy-
mia should be chronologically measured repeatedly in
the same individuals. Second, alexithymia and negative
affect are closely associated. Also, interactions with so-
cial support cannot be dismissed when examining the in-
fluence of alexithymia on health problems. Thus, social
support as well as negative affect must be assessed sim-
ultaneously when evaluating alexithymia to exclude po-
tential confounding in statistical analysis. Third, if the
pre-test score is extremely high, it is likely to show a
drop in the post-test score; “regression to the mean
[63].” People with alexithymia tend to have higher scores
of distress than people without alexithymia. Therefore,
simple subtraction of the post-treatment score from the
pre-treatment score may cause overestimation of the
treatment effect. Using the residual gain score, which is
the difference between the actual post-test score and the
score that was predicted from a regression equation is
one method to adjust the phenomenon, and the use of
the analyses of covariance method is also recommended
[63]. Finally, as suggested by Grabe et al, alexithymia is
considered to be a long-standing risk factor as well as a
familial and genetic factor of health [21]. To detect the
association between alexithymia and the developmental
risk of specific health problems, a long observational
period is required. Especially, the association between
alexithymia and the onset of depression may occur at a
relatively early stage of life. If so, prospective study of
the middle-aged population may omit persons who have
already developed depression due to alexithymia and
overlook the association between them.
Alexithymia might explain social health inequality
Marmot, who directed the Whitehall Study, a longitu-
dinal epidemiological study of British civil servants,
pointed out from his 30 years of research that there are
great health inequalities throughout the world that are
related to social hierarchy [64-66]. According to Mar-
mot’s speculations, what profoundly affects our health
and longevity is not income or lifestyle but autonomy
and the opportunities for complete social participation;
these follow social gradients and result in health inequal-
ities [66]. Externally oriented thinking styles may inhibit
alexithymic patients from feeling like they are in control,
and their difficulty in “identifying and describing ones’
own inner feelings” may make them reluctant to partici-
pate in social activities. To date, there are two published
studies reporting the association between alexithymia
and long-term total mortality [15,27], and both of themsupported the above hypothesis. Considering its con-
struct, alexithymia might be a key health determinant, as
Marmot suggested [65]. In order to resolve social in-
equalities and improve our health, we should approach
the structure of the whole society to reduce alexithymia
urgently. Recently, several researchers reported success-
ful interventions to reduce the level of alexithymia
[42,51,67,68]. We need more evidence to establish the
treatment strategy for alexithymia.
How to approach alexithymia
The etiology of alexithymia has not been completely
determined. Recent studies revealed the contribution of
genetic factors to alexithymia development [69-74]. Sev-
eral studies suggested that the social environment of
early life and cultural factors influence alexithymia de-
velopment [75-77]. Alexithymia is also known to develop
secondarily as a reaction to stressful situations [78].
Moreover, some constructs may overlap with alexithymia
[4,79], such as emotional intelligence, emotional aware-
ness, empathy deficits [80,81], and autism spectrum dis-
orders [82,83]. How a person develops alexithymic
characteristics and how it affects his or her health
throughout the life course need to be clarified. We also
need to know how to approach alexithymic patients
when their developmental backgrounds are varied.
Current review has revealed some favorable influences
of alexithymia on surgical treatment outcomes [42-46].
A positive influence of alexithymia on behavioral treat-
ments and adherence to treatment recommendations
has been observed in several previous studies [4]. Lum-
ley et al speculated that the compulsive nature and ex-
ternal focus of alexithymic patients prompt greater
adherence to structured exercises and behavioral recom-
mendations [4]. If clinicians and family members under-
stand the characteristics of alexithymic patients and
provide them with appropriate support, they might ex-
hibit good compliance and thereby achieve good health
outcomes. This point should be further explored in fu-
ture studies.
Study limitation
To conduct the current systematic review, only the
PubMed database for a limited period was used for the
article search. The results of unpublished studies or arti-
cles not registered for PubMed were not included.
Therefore, this systematic review did not cover all exist-
ing studies regarding alexithymia and the data need to
be updated.
Almost all epidemiological studies reviewed in this art-
icle used the TAS or its short version, the TAS-20, to
evaluate alexithymia. Both of them are self-measure
questionnaires and have been used widely because of
their good reliability and feasibility [84]. However, it has
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not evaluate their symptoms correctly because of having
difficulty perceiving their inner feelings [85]. Moreover, a
significant positive correlation of the TAS or the TAS-20
score and negative affect has been reported consistently
[84]. The original authors of the TAS have recom-
mended the measurement of alexithymia with several
tools using different methods [8]. Whether or not we
should use multiple measures of alexithymia has been
very well discussed in the review article by Lumley et al
[4]. Even though the application of interview-based as-
sessment to epidemiological studies with large samples
is difficult, the differences in measuring tools, especially
those that include objective measures, should be verified
in the future.
Conclusions
The epidemiological evidence regarding alexithymia as a
prognostic risk factor for health problems is insufficient.
Prospective studies with sufficient sample sizes will be
necessary in order to confirm the contribution of alex-
ithymia to health problems.
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